等待開盤 12-13 09:30:00 美东时间
+0.830
+0.49%
Barclays analyst Benjamin Budish maintains Virtus Inv (NYSE:VRTS) with a Underweight and lowers the price target from $175 to $158.
今天 04:34
Virtus Investment (VRTS) declared $2.40/share quarterly dividend, in line with previous. Forward yield 5.84% Payable Feb. 11; for shareholders of record Jan. 31; ex-div Jan. 30. See VRTS Dividend Scor...
12-11 20:59
Virtus Investment Partners (VRTS) on Wednesday announced preliminary assets under management of $164.2B as of November 30, compared to $166.2B at the end of October. The decrease reflects market perfo...
12-10 20:19
Amy Raskin, CIO at Chevy Chase Trust, named Ascendis Pharma (ASND) as her final trade on CNBC's Halftime Report. FDA extended review for TransCon CNP.
12-09 21:16
Expands Capabilities into Private Markets with a Differentiated Offering Focused on Asset-Backed LendingVirtus Investment Partners, Inc. (NYSE:VRTS), which operates a multi-manager asset management business, today
12-05 21:50
CrowdStrike, Global X Cybersecurity ETF, Prologis and Amazon are among the final picks on the latest edition of CNBC's "Final Trades."
12-01 21:05
Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage.
11-18 21:08
Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his final trade.
11-05 21:26
Final trades on CNBC's Halftime Report: Vistra Corp. named top trade, PayPal CEO engineering turnaround, Netflix & Invesco QQQ Trust also mentioned.
10-29 19:47
今日重点评级关注:HC Wainwright & Co.:维持PepGen"买入"评级,目标价从12美元升至18美元;Piper Sandler:维持Prothena Corp"超配"评级,目标价从15美元升至36美元
10-29 09:25